Given the contrast between the modest effect sizes attributable to individual variants and the relatively large impact of environmental control that can be exerted (e.g., increasing taxation, prohibition of use in public places), are genetic studies of addiction worthwhile [107]? Perhaps the most compelling response to this question comes from emerging pharmacogenetic efforts that attempt to tailor pharmacotherapy based on genotype.
